Assets
| Type | Time | Amount | Unit |
|---|---|---|---|
| ifrs-full:Assets | 2016-12-31 | 18018258 | u0 |
| ifrs-full:Assets | 2015-12-31 | 3857934 | u0 |
Revenue
| Type | Start date | End date | Amount | Unit |
|---|
XML
See the xml submitted here:
XML: http://regnskaber.virk.dk/98394253/ZG9rdW1lbnRsYWdlcjovLzAzL2EyL2MwLzYwLzkzLzhjNTktNGE5MS1iZjU5LTBkZDZjZGJkY2RkZA.xml
Separator
The full data:
<?xml version="1.0" encoding="UTF-8"?><xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:f="http://xbrl.dcca.dk/sob" xmlns:b="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature" xmlns:h="http://xbrl.dcca.dk/mrv" xmlns:g="http://xbrl.dcca.dk/arr" xmlns:d="http://xbrl.dcca.dk/cmn" xmlns:e="http://xbrl.dcca.dk/fsa" xmlns:c="http://xbrl.dcca.dk/gsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://xbrl.dcca.dk/entryBalanceSheetAccountFormIncomeStatementByNature http://archprod.service.eogs.dk/taxonomy/20161001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20161001.xsd"><link:schemaRef xlink:type="simple" xlink:href="http://archprod.service.eogs.dk/taxonomy/20161001/entryDanishGAAPBalanceSheetAccountFormIncomeStatementByNatureIncludingManagementsReviewStatisticsAndTax20161001.xsd"/><c:InformationOnTypeOfSubmittedReport contextRef="c65">Ã
rsrapport</c:InformationOnTypeOfSubmittedReport><c:IdentificationNumberCvrOfSubmittingEnterprise contextRef="c65">33771231</c:IdentificationNumberCvrOfSubmittingEnterprise><c:NameOfSubmittingEnterprise contextRef="c65">PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab</c:NameOfSubmittingEnterprise><c:AddressOfSubmittingEnterpriseStreetAndNumber contextRef="c65">Strandvejen 44</c:AddressOfSubmittingEnterpriseStreetAndNumber><c:AddressOfSubmittingEnterprisePostcodeAndTown contextRef="c65">2900 Hellerup</c:AddressOfSubmittingEnterprisePostcodeAndTown><c:ReportingPeriodStartDate contextRef="c65">2016-01-01</c:ReportingPeriodStartDate><c:PrecedingReportingPeriodStartDate contextRef="c65">2015-01-01</c:PrecedingReportingPeriodStartDate><c:ReportingPeriodEndDate contextRef="c65">2016-12-31</c:ReportingPeriodEndDate><c:PredingReportingPeriodEndDate contextRef="c65">2015-12-31</c:PredingReportingPeriodEndDate><c:IdentificationNumberCvrOfReportingEntity contextRef="c65">35249389</c:IdentificationNumberCvrOfReportingEntity><c:NameOfReportingEntity contextRef="c65">Curasight ApS</c:NameOfReportingEntity><c:AddressOfReportingEntityStreetName contextRef="c65">Ole Maaløes Vej</c:AddressOfReportingEntityStreetName><c:AddressOfReportingEntityStreetBuildingIdentifier contextRef="c65">3</c:AddressOfReportingEntityStreetBuildingIdentifier><c:AddressOfReportingEntityPostCodeIdentifier contextRef="c65">2200</c:AddressOfReportingEntityPostCodeIdentifier><c:AddressOfReportingEntityDistrictName contextRef="c65">Copenhagen N</c:AddressOfReportingEntityDistrictName><c:RegisteredOfficeOfReportingEntity contextRef="c65">Copenhagen</c:RegisteredOfficeOfReportingEntity><c:TelephoneNumberOfReportingEntity contextRef="c65">61262218</c:TelephoneNumberOfReportingEntity><c:EmailOfReportingEntity contextRef="c65">mp@curasight.com</c:EmailOfReportingEntity><d:NameOfAuditFirm contextRef="c67">PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab</d:NameOfAuditFirm><d:IdentificationNumberCvrOfAuditFirm contextRef="c67">33771231</d:IdentificationNumberCvrOfAuditFirm><c:AddressOfAuditorStreetName contextRef="c67">Strandvejen</c:AddressOfAuditorStreetName><c:AddressOfAuditorStreetBuildingIdentifier contextRef="c67">44</c:AddressOfAuditorStreetBuildingIdentifier><c:AddressOfAuditorPostCodeIdentifier contextRef="c67">2900</c:AddressOfAuditorPostCodeIdentifier><c:AddressOfAuditorDistrictName contextRef="c67">Hellerup</c:AddressOfAuditorDistrictName><c:AddressOfAuditorCountry contextRef="c65">Danmark</c:AddressOfAuditorCountry><c:DateOfGeneralMeeting contextRef="c65">2017-05-04</c:DateOfGeneralMeeting><c:NameAndSurnameOfChairmanOfGeneralMeeting contextRef="c65">Lars Trolle</c:NameAndSurnameOfChairmanOfGeneralMeeting><e:ClassOfReportingEntity contextRef="c65">Regnskabsklasse B</e:ClassOfReportingEntity><e:SelectedElementsFromReportingClassC contextRef="c65">1</e:SelectedElementsFromReportingClassC><d:TypeOfAuditorAssistance contextRef="c65">RevisionspÃ¥tegning</d:TypeOfAuditorAssistance><f:PlaceOfSignatureOfStatement contextRef="c65">København N</f:PlaceOfSignatureOfStatement><f:DateOfApprovalOfAnnualReport contextRef="c65">2017-05-04</f:DateOfApprovalOfAnnualReport><d:NameAndSurnameOfMemberOfExecutiveBoard contextRef="c83">Morten Persson</d:NameAndSurnameOfMemberOfExecutiveBoard><d:TitleOfMemberOfExecutiveBoard contextRef="c83">CEO</d:TitleOfMemberOfExecutiveBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c68">Lars Trolle</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:TitleOfMemberOfSupervisoryBoard contextRef="c68">Chairman</d:TitleOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c69">Ulf Lennart Rosén</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c70">André Klaus Hess</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c71">Nicolas Némery</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c72">Ulrich Alexander Krasilnikoff</d:NameAndSurnameOfMemberOfSupervisoryBoard><d:NameAndSurnameOfMemberOfSupervisoryBoard contextRef="c73">Andreas Kjær</d:NameAndSurnameOfMemberOfSupervisoryBoard><g:SignatureOfAuditorsPlace contextRef="c65">Hellerup</g:SignatureOfAuditorsPlace><g:SignatureOfAuditorsDate contextRef="c65">2017-05-04</g:SignatureOfAuditorsDate><g:SignatureOfAuditorsPlace contextRef="c65">Hellerup</g:SignatureOfAuditorsPlace><g:SignatureOfAuditorsDate contextRef="c65">2017-05-04</g:SignatureOfAuditorsDate><d:NameOfAuditFirm contextRef="c67">PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab</d:NameOfAuditFirm><d:NameAndSurnameOfAuditor contextRef="c67">Jacob F Christiansen</d:NameAndSurnameOfAuditor><d:DescriptionOfAuditor contextRef="c67">State Authorised Public Accountant</d:DescriptionOfAuditor><d:NameAndSurnameOfAuditor contextRef="c66">Henrik Y Jensen</d:NameAndSurnameOfAuditor><d:DescriptionOfAuditor contextRef="c66">State Authorised Public Accountant</d:DescriptionOfAuditor><e:GrossProfitLoss contextRef="c65" unitRef="u0" decimals="0">-1706678</e:GrossProfitLoss><e:GrossProfitLoss contextRef="c92" unitRef="u0" decimals="0">-599552</e:GrossProfitLoss><e:EmployeeBenefitsExpense contextRef="c65" unitRef="u0" decimals="0">2168556</e:EmployeeBenefitsExpense><e:EmployeeBenefitsExpense contextRef="c92" unitRef="u0" decimals="0">538423</e:EmployeeBenefitsExpense><e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c65" unitRef="u0" decimals="0">154317</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c92" unitRef="u0" decimals="0">115864</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><e:ProfitLossFromOrdinaryOperatingActivities contextRef="c65" unitRef="u0" decimals="0">-4029551</e:ProfitLossFromOrdinaryOperatingActivities><e:ProfitLossFromOrdinaryOperatingActivities contextRef="c92" unitRef="u0" decimals="0">-1253839</e:ProfitLossFromOrdinaryOperatingActivities><e:OtherFinanceIncome contextRef="c65" unitRef="u0" decimals="0">0</e:OtherFinanceIncome><e:OtherFinanceIncome contextRef="c92" unitRef="u0" decimals="0">1368</e:OtherFinanceIncome><e:OtherFinanceExpenses contextRef="c65" unitRef="u0" decimals="0">13467</e:OtherFinanceExpenses><e:OtherFinanceExpenses contextRef="c92" unitRef="u0" decimals="0">1083</e:OtherFinanceExpenses><e:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c65" unitRef="u0" decimals="0">-4043018</e:ProfitLossFromOrdinaryActivitiesBeforeTax><e:ProfitLossFromOrdinaryActivitiesBeforeTax contextRef="c92" unitRef="u0" decimals="0">-1253554</e:ProfitLossFromOrdinaryActivitiesBeforeTax><e:TaxExpense contextRef="c65" unitRef="u0" decimals="0">-882226</e:TaxExpense><e:TaxExpense contextRef="c92" unitRef="u0" decimals="0">-124124</e:TaxExpense><e:ProfitLoss contextRef="c65" unitRef="u0" decimals="0">-3160792</e:ProfitLoss><e:ProfitLoss contextRef="c92" unitRef="u0" decimals="0">-1129430</e:ProfitLoss><e:ProfitLoss contextRef="c105" unitRef="u0" decimals="0">-3160792</e:ProfitLoss><e:ProfitLoss contextRef="c106" unitRef="u0" decimals="0">-1129430</e:ProfitLoss><e:CompletedDevelopmentProjects contextRef="c110" unitRef="u0" decimals="0">0</e:CompletedDevelopmentProjects><e:CompletedDevelopmentProjects contextRef="c109" unitRef="u0" decimals="0">0</e:CompletedDevelopmentProjects><e:AcquiredPatents contextRef="c110" unitRef="u0" decimals="0">864286</e:AcquiredPatents><e:AcquiredPatents contextRef="c109" unitRef="u0" decimals="0">473736</e:AcquiredPatents><e:DevelopmentProjectsInProgress contextRef="c110" unitRef="u0" decimals="0">12314334</e:DevelopmentProjectsInProgress><e:DevelopmentProjectsInProgress contextRef="c109" unitRef="u0" decimals="0">2716983</e:DevelopmentProjectsInProgress><e:IntangibleAssets contextRef="c110" unitRef="u0" decimals="0">13178620</e:IntangibleAssets><e:IntangibleAssets contextRef="c109" unitRef="u0" decimals="0">3190719</e:IntangibleAssets><e:FixturesFittingsToolsAndEquipment contextRef="c110" unitRef="u0" decimals="0">377478</e:FixturesFittingsToolsAndEquipment><e:FixturesFittingsToolsAndEquipment contextRef="c109" unitRef="u0" decimals="0">0</e:FixturesFittingsToolsAndEquipment><e:PropertyPlantAndEquipment contextRef="c110" unitRef="u0" decimals="0">377478</e:PropertyPlantAndEquipment><e:PropertyPlantAndEquipment contextRef="c109" unitRef="u0" decimals="0">0</e:PropertyPlantAndEquipment><e:NoncurrentAssets contextRef="c110" unitRef="u0" decimals="0">13556098</e:NoncurrentAssets><e:NoncurrentAssets contextRef="c109" unitRef="u0" decimals="0">3190719</e:NoncurrentAssets><e:OtherShorttermReceivables contextRef="c110" unitRef="u0" decimals="0">172914</e:OtherShorttermReceivables><e:OtherShorttermReceivables contextRef="c109" unitRef="u0" decimals="0">121860</e:OtherShorttermReceivables><e:ShorttermTaxReceivables contextRef="c110" unitRef="u0" decimals="0">2104818</e:ShorttermTaxReceivables><e:ShorttermTaxReceivables contextRef="c109" unitRef="u0" decimals="0">397056</e:ShorttermTaxReceivables><e:ShorttermReceivables contextRef="c110" unitRef="u0" decimals="0">2277732</e:ShorttermReceivables><e:ShorttermReceivables contextRef="c109" unitRef="u0" decimals="0">518916</e:ShorttermReceivables><e:CashAndCashEquivalents contextRef="c110" unitRef="u0" decimals="0">2184428</e:CashAndCashEquivalents><e:CashAndCashEquivalents contextRef="c109" unitRef="u0" decimals="0">148299</e:CashAndCashEquivalents><e:CurrentAssets contextRef="c110" unitRef="u0" decimals="0">4462160</e:CurrentAssets><e:CurrentAssets contextRef="c109" unitRef="u0" decimals="0">667215</e:CurrentAssets><e:Assets contextRef="c110" unitRef="u0" decimals="0">18018258</e:Assets><e:Assets contextRef="c109" unitRef="u0" decimals="0">3857934</e:Assets><e:ContributedCapital contextRef="c110" unitRef="u0" decimals="0">180007</e:ContributedCapital><e:ContributedCapital contextRef="c109" unitRef="u0" decimals="0">119179</e:ContributedCapital><e:PaidContributedCapital contextRef="c110" unitRef="u0" decimals="0">180007</e:PaidContributedCapital><e:PaidContributedCapital contextRef="c109" unitRef="u0" decimals="0">119179</e:PaidContributedCapital><e:SharePremium contextRef="c110" unitRef="u0" decimals="0">0</e:SharePremium><e:SharePremium contextRef="c109" unitRef="u0" decimals="0">4545721</e:SharePremium><e:ReserveForDevelopmentExpenditure contextRef="c110" unitRef="u0" decimals="0">7485935</e:ReserveForDevelopmentExpenditure><e:ReserveForDevelopmentExpenditure contextRef="c109" unitRef="u0" decimals="0">0</e:ReserveForDevelopmentExpenditure><e:RetainedEarnings contextRef="c110" unitRef="u0" decimals="0">41839</e:RetainedEarnings><e:RetainedEarnings contextRef="c109" unitRef="u0" decimals="0">-1399827</e:RetainedEarnings><e:Equity contextRef="c110" unitRef="u0" decimals="0">7707781</e:Equity><e:Equity contextRef="c109" unitRef="u0" decimals="0">3265073</e:Equity><e:ProvisionsForDeferredTax contextRef="c110" unitRef="u0" decimals="0">1410521</e:ProvisionsForDeferredTax><e:ProvisionsForDeferredTax contextRef="c109" unitRef="u0" decimals="0">187930</e:ProvisionsForDeferredTax><e:Provisions contextRef="c110" unitRef="u0" decimals="0">1410521</e:Provisions><e:Provisions contextRef="c109" unitRef="u0" decimals="0">187930</e:Provisions><e:ShorttermDebtToOtherCreditInstitutions contextRef="c110" unitRef="u0" decimals="0">0</e:ShorttermDebtToOtherCreditInstitutions><e:ShorttermDebtToOtherCreditInstitutions contextRef="c109" unitRef="u0" decimals="0">23804</e:ShorttermDebtToOtherCreditInstitutions><e:ShorttermTradePayables contextRef="c110" unitRef="u0" decimals="0">2305261</e:ShorttermTradePayables><e:ShorttermTradePayables contextRef="c109" unitRef="u0" decimals="0">22500</e:ShorttermTradePayables><e:ShorttermPayablesToShareholdersAndManagement contextRef="c110" unitRef="u0" decimals="0">6274931</e:ShorttermPayablesToShareholdersAndManagement><e:ShorttermPayablesToShareholdersAndManagement contextRef="c109" unitRef="u0" decimals="0">0</e:ShorttermPayablesToShareholdersAndManagement><e:OtherShorttermPayables contextRef="c110" unitRef="u0" decimals="0">169764</e:OtherShorttermPayables><e:OtherShorttermPayables contextRef="c109" unitRef="u0" decimals="0">208627</e:OtherShorttermPayables><e:ShorttermDeferredIncome contextRef="c110" unitRef="u0" decimals="0">150000</e:ShorttermDeferredIncome><e:ShorttermDeferredIncome contextRef="c109" unitRef="u0" decimals="0">150000</e:ShorttermDeferredIncome><e:ShorttermLiabilitiesOtherThanProvisions contextRef="c110" unitRef="u0" decimals="0">8899956</e:ShorttermLiabilitiesOtherThanProvisions><e:ShorttermLiabilitiesOtherThanProvisions contextRef="c109" unitRef="u0" decimals="0">404931</e:ShorttermLiabilitiesOtherThanProvisions><e:LiabilitiesOtherThanProvisions contextRef="c110" unitRef="u0" decimals="0">8899956</e:LiabilitiesOtherThanProvisions><e:LiabilitiesOtherThanProvisions contextRef="c109" unitRef="u0" decimals="0">404931</e:LiabilitiesOtherThanProvisions><e:LiabilitiesAndEquity contextRef="c110" unitRef="u0" decimals="0">18018258</e:LiabilitiesAndEquity><e:LiabilitiesAndEquity contextRef="c109" unitRef="u0" decimals="0">3857934</e:LiabilitiesAndEquity><e:Equity contextRef="c0" unitRef="u0" decimals="0">119179</e:Equity><e:Equity contextRef="c5" unitRef="u0" decimals="0">4545721</e:Equity><e:Equity contextRef="c2473" unitRef="u0" decimals="0">0</e:Equity><e:Equity contextRef="c20" unitRef="u0" decimals="0">-1399827</e:Equity><e:IncreaseOfCapital contextRef="c1" unitRef="u0" decimals="0">60828</e:IncreaseOfCapital><e:IncreaseOfCapital contextRef="c6" unitRef="u0" decimals="0">7542672</e:IncreaseOfCapital><e:IncreaseOfCapital contextRef="c2474" unitRef="u0" decimals="0">0</e:IncreaseOfCapital><e:IncreaseOfCapital contextRef="c21" unitRef="u0" decimals="0">0</e:IncreaseOfCapital><e:EquityTransfersToReserves contextRef="c1" unitRef="u0" decimals="0">0</e:EquityTransfersToReserves><e:EquityTransfersToReserves contextRef="c6" unitRef="u0" decimals="0">0</e:EquityTransfersToReserves><e:EquityTransfersToReserves contextRef="c2474" unitRef="u0" decimals="0">7485935</e:EquityTransfersToReserves><e:EquityTransfersToReserves contextRef="c21" unitRef="u0" decimals="0">-7485935</e:EquityTransfersToReserves><e:ProfitLoss contextRef="c2474" unitRef="u0" decimals="0">0</e:ProfitLoss><e:ProfitLoss contextRef="c21" unitRef="u0" decimals="0">-3160792</e:ProfitLoss><e:TransferredFromSharePremium contextRef="c6" unitRef="u0" decimals="0">-12088393</e:TransferredFromSharePremium><e:TransferredFromSharePremium contextRef="c21" unitRef="u0" decimals="0">12088393</e:TransferredFromSharePremium><e:Equity contextRef="c2" unitRef="u0" decimals="0">180007</e:Equity><e:Equity contextRef="c7" unitRef="u0" decimals="0">0</e:Equity><e:Equity contextRef="c2475" unitRef="u0" decimals="0">7485935</e:Equity><e:Equity contextRef="c22" unitRef="u0" decimals="0">41839</e:Equity><e:WagesAndSalaries contextRef="c65" unitRef="u0" decimals="0">2443529</e:WagesAndSalaries><e:WagesAndSalaries contextRef="c92" unitRef="u0" decimals="0">1526291</e:WagesAndSalaries><e:PostemploymentBenefitExpense contextRef="c65" unitRef="u0" decimals="0">148000</e:PostemploymentBenefitExpense><e:PostemploymentBenefitExpense contextRef="c92" unitRef="u0" decimals="0">120000</e:PostemploymentBenefitExpense><e:SocialSecurityContributions contextRef="c65" unitRef="u0" decimals="0">7698</e:SocialSecurityContributions><e:SocialSecurityContributions contextRef="c92" unitRef="u0" decimals="0">9109</e:SocialSecurityContributions><e:OtherEmployeeExpense contextRef="c65" unitRef="u0" decimals="0">130241</e:OtherEmployeeExpense><e:OtherEmployeeExpense contextRef="c92" unitRef="u0" decimals="0">119842</e:OtherEmployeeExpense><e:EmployeeExpensesTransferredToAssets contextRef="c65" unitRef="u0" decimals="0">-560912</e:EmployeeExpensesTransferredToAssets><e:EmployeeExpensesTransferredToAssets contextRef="c92" unitRef="u0" decimals="0">-1236819</e:EmployeeExpensesTransferredToAssets><e:EmployeeBenefitsExpense contextRef="c65" unitRef="u0" decimals="0">2168556</e:EmployeeBenefitsExpense><e:EmployeeBenefitsExpense contextRef="c92" unitRef="u0" decimals="0">538423</e:EmployeeBenefitsExpense><e:AverageNumberOfEmployees contextRef="c65" unitRef="u2" decimals="INF">5</e:AverageNumberOfEmployees><e:AverageNumberOfEmployees contextRef="c92" unitRef="u2" decimals="INF">3</e:AverageNumberOfEmployees><e:AmortisationOfIntangibleAssets contextRef="c65" unitRef="u0" decimals="0">134450</e:AmortisationOfIntangibleAssets><e:AmortisationOfIntangibleAssets contextRef="c92" unitRef="u0" decimals="0">115864</e:AmortisationOfIntangibleAssets><e:DepreciationOfPropertyPlantAndEquipment contextRef="c65" unitRef="u0" decimals="0">19867</e:DepreciationOfPropertyPlantAndEquipment><e:DepreciationOfPropertyPlantAndEquipment contextRef="c92" unitRef="u0" decimals="0">0</e:DepreciationOfPropertyPlantAndEquipment><e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c65" unitRef="u0" decimals="0">154317</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss contextRef="c92" unitRef="u0" decimals="0">115864</e:DepreciationAmortisationExpenseAndImpairmentLossesOfPropertyPlantAndEquipmentAndIntangibleAssetsRecognisedInProfitOrLoss><e:OtherInterestIncome contextRef="c65" unitRef="u0" decimals="0">0</e:OtherInterestIncome><e:OtherInterestIncome contextRef="c92" unitRef="u0" decimals="0">1368</e:OtherInterestIncome><e:OtherInterestExpenses contextRef="c65" unitRef="u0" decimals="0">13350</e:OtherInterestExpenses><e:OtherInterestExpenses contextRef="c92" unitRef="u0" decimals="0">1083</e:OtherInterestExpenses><e:ExchangeRateLoss contextRef="c65" unitRef="u0" decimals="0">117</e:ExchangeRateLoss><e:ExchangeRateLoss contextRef="c92" unitRef="u0" decimals="0">0</e:ExchangeRateLoss><e:OtherFinanceExpenses contextRef="c65" unitRef="u0" decimals="0">13467</e:OtherFinanceExpenses><e:OtherFinanceExpenses contextRef="c92" unitRef="u0" decimals="0">1083</e:OtherFinanceExpenses><e:CurrentTaxExpense contextRef="c65" unitRef="u0" decimals="0">-2104817</e:CurrentTaxExpense><e:CurrentTaxExpense contextRef="c92" unitRef="u0" decimals="0">-397056</e:CurrentTaxExpense><e:AdjustmentsForDeferredTax contextRef="c65" unitRef="u0" decimals="0">1222591</e:AdjustmentsForDeferredTax><e:AdjustmentsForDeferredTax contextRef="c92" unitRef="u0" decimals="0">89926</e:AdjustmentsForDeferredTax><e:AdjustmentsForCurrentTaxRelatingToTaxRateChangesOrImpositionOfNewTaxes contextRef="c65" unitRef="u0" decimals="0">0</e:AdjustmentsForCurrentTaxRelatingToTaxRateChangesOrImpositionOfNewTaxes><e:AdjustmentsForCurrentTaxRelatingToTaxRateChangesOrImpositionOfNewTaxes contextRef="c92" unitRef="u0" decimals="0">183006</e:AdjustmentsForCurrentTaxRelatingToTaxRateChangesOrImpositionOfNewTaxes><e:TaxExpenseOnOrdinaryActivities contextRef="c65" unitRef="u0" decimals="0">-882226</e:TaxExpenseOnOrdinaryActivities><e:TaxExpenseOnOrdinaryActivities contextRef="c92" unitRef="u0" decimals="0">-124124</e:TaxExpenseOnOrdinaryActivities><e:IntangibleAssetsGross contextRef="c329" unitRef="u0" decimals="0">263400</e:IntangibleAssetsGross><e:IntangibleAssetsGross contextRef="c330" unitRef="u0" decimals="0">414000</e:IntangibleAssetsGross><e:IntangibleAssetsGross contextRef="c332" unitRef="u0" decimals="0">2716982</e:IntangibleAssetsGross><e:AdditionsToIntangibleAssets contextRef="c342" unitRef="u0" decimals="0">0</e:AdditionsToIntangibleAssets><e:AdditionsToIntangibleAssets contextRef="c340" unitRef="u0" decimals="0">525000</e:AdditionsToIntangibleAssets><e:AdditionsToIntangibleAssets contextRef="c336" unitRef="u0" decimals="0">9597352</e:AdditionsToIntangibleAssets><e:IntangibleAssetsGross contextRef="c343" unitRef="u0" decimals="0">263400</e:IntangibleAssetsGross><e:IntangibleAssetsGross contextRef="c341" unitRef="u0" decimals="0">939000</e:IntangibleAssetsGross><e:IntangibleAssetsGross contextRef="c337" unitRef="u0" decimals="0">12314334</e:IntangibleAssetsGross><e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c329" unitRef="u0" decimals="0">175600</e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets><e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c330" unitRef="u0" decimals="0">28064</e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets><e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c332" unitRef="u0" decimals="0">0</e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets><e:AmortisationOfIntangibleAssets contextRef="c342" unitRef="u0" decimals="0">87800</e:AmortisationOfIntangibleAssets><e:AmortisationOfIntangibleAssets contextRef="c340" unitRef="u0" decimals="0">46650</e:AmortisationOfIntangibleAssets><e:AmortisationOfIntangibleAssets contextRef="c336" unitRef="u0" decimals="0">0</e:AmortisationOfIntangibleAssets><e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c343" unitRef="u0" decimals="0">263400</e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets><e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c341" unitRef="u0" decimals="0">74714</e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets><e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets contextRef="c337" unitRef="u0" decimals="0">0</e:AccumulatedImpairmentLossesAndAmortisationOfIntangibleAssets><e:IntangibleAssets contextRef="c343" unitRef="u0" decimals="0">0</e:IntangibleAssets><e:IntangibleAssets contextRef="c341" unitRef="u0" decimals="0">864286</e:IntangibleAssets><e:IntangibleAssets contextRef="c337" unitRef="u0" decimals="0">12314334</e:IntangibleAssets><e:PropertyPlantAndEquipmentGross contextRef="c188" unitRef="u0" decimals="0">0</e:PropertyPlantAndEquipmentGross><e:AdditionsToPropertyPlantAndEquipment contextRef="c189" unitRef="u0" decimals="0">397345</e:AdditionsToPropertyPlantAndEquipment><e:PropertyPlantAndEquipmentGross contextRef="c190" unitRef="u0" decimals="0">397345</e:PropertyPlantAndEquipmentGross><e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c188" unitRef="u0" decimals="0">0</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment><e:DepreciationOfPropertyPlantAndEquipment contextRef="c189" unitRef="u0" decimals="0">19867</e:DepreciationOfPropertyPlantAndEquipment><e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment contextRef="c190" unitRef="u0" decimals="0">19867</e:AccumulatedImpairmentLossesAndDepreciationOfPropertyPlantAndEquipment><e:PropertyPlantAndEquipment contextRef="c190" unitRef="u0" decimals="0">377478</e:PropertyPlantAndEquipment><e:DescriptionOfClassOfIssuedShares contextRef="c119">A-shares</e:DescriptionOfClassOfIssuedShares><e:NumberOfIssuedShares contextRef="c119" unitRef="u3" decimals="INF">80000</e:NumberOfIssuedShares><e:NominalValueOfIssuedShares contextRef="c119" unitRef="u0" decimals="0">80000</e:NominalValueOfIssuedShares><e:DescriptionOfClassOfIssuedShares contextRef="c120">B-shares</e:DescriptionOfClassOfIssuedShares><e:NumberOfIssuedShares contextRef="c120" unitRef="u3" decimals="INF">39179</e:NumberOfIssuedShares><e:NominalValueOfIssuedShares contextRef="c120" unitRef="u0" decimals="0">39179</e:NominalValueOfIssuedShares><e:DescriptionOfClassOfIssuedShares contextRef="c121">C-shares</e:DescriptionOfClassOfIssuedShares><e:NumberOfIssuedShares contextRef="c121" unitRef="u3" decimals="INF">60828</e:NumberOfIssuedShares><e:NominalValueOfIssuedShares contextRef="c121" unitRef="u0" decimals="0">60828</e:NominalValueOfIssuedShares><e:Equity contextRef="c123" unitRef="u0" decimals="0">101953</e:Equity><e:Equity contextRef="c126" unitRef="u0" decimals="0">80000</e:Equity><e:Equity contextRef="c129" unitRef="u0" decimals="0">80000</e:Equity><e:IncreaseOfCapital contextRef="c124" unitRef="u0" decimals="0">17226</e:IncreaseOfCapital><e:IncreaseOfCapital contextRef="c127" unitRef="u0" decimals="0">21953</e:IncreaseOfCapital><e:IncreaseOfCapital contextRef="c130" unitRef="u0" decimals="0">0</e:IncreaseOfCapital><e:DecreaseOfCapital contextRef="c124" unitRef="u0" decimals="0">0</e:DecreaseOfCapital><e:DecreaseOfCapital contextRef="c127" unitRef="u0" decimals="0">0</e:DecreaseOfCapital><e:DecreaseOfCapital contextRef="c130" unitRef="u0" decimals="0">0</e:DecreaseOfCapital><e:Equity contextRef="c125" unitRef="u0" decimals="0">119179</e:Equity><e:Equity contextRef="c128" unitRef="u0" decimals="0">101953</e:Equity><e:Equity contextRef="c131" unitRef="u0" decimals="0">80000</e:Equity><f:IdentificationOfApprovedAnnualReport contextRef="c65">The Executive Board and Board of Directors have today considered and adopted the Annual Report of Curasight ApS for the financial year 1 January - 31 December 2016.</f:IdentificationOfApprovedAnnualReport><f:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement contextRef="c65">The Annual Report is prepared in accordance with the Danish Financial Statements Act.</f:ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement><f:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults contextRef="c65">In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2016 of the Company and of the results of the Company operations for 2016.</f:ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults><f:RecommendationForApprovalOfAnnualReportByGeneralMeeting contextRef="c65">We recommend that the Annual Report be adopted at the Annual General Meeting.</f:RecommendationForApprovalOfAnnualReportByGeneralMeeting><g:AddresseeOfAuditorsReportOnAuditedFinancialStatements contextRef="c65">To the Shareholders of Curasight ApS</g:AddresseeOfAuditorsReportOnAuditedFinancialStatements><g:OpinionOnAuditedFinancialStatements contextRef="c65">In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2016 and of the results of the Companyâs operations for the financial year 1 January - 31 December 2016 in accordance with the Danish Financial Statements Act.
</g:OpinionOnAuditedFinancialStatements><g:IdentificationOfAuditedFinancialStatements contextRef="c65">We have audited the Financial Statements of Curasight ApS for the financial year 1 January - 31 December 2016, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies (âthe Financial Statementsâ).
</g:IdentificationOfAuditedFinancialStatements><g:DescriptionOfQualificationsOfAuditedFinancialStatements contextRef="c65">We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the âAuditorâs responsibilities for the audit of the Financial Statementsâ section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountantsâ Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
</g:DescriptionOfQualificationsOfAuditedFinancialStatements><g:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements contextRef="c65">Management is responsible for Managementâs Review.
Our opinion on the Financial Statements does not cover Managementâs Review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the Financial Statements, our responsibility is to read Managementâs Review and, in doing so, consider whether Managementâs Review is materially inconsistent with the Financial Statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether Managementâs Review provides the information required under the Danish Financials Statements Act.
Based on the work we have performed, in our view, Managementâs Review is in accordance with the Financial Statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement in Managementâs Review.
</g:StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements><g:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements contextRef="c65">Management is responsible for the preparation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act, and for such internal control as Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the Financial Statements, Management is responsible for assessing the Companyâs ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting in preparing the Financial Statements unless Management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.
</g:StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements><g:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed contextRef="c65">Our objectives are to obtain reasonable assurance about whether the Financial Statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditorâs report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Financial Statements.
As part of an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark, we exercise professional judgement and maintain professional scepticism throughout the audit. We also:
Identify and assess the risks of material misstatement of the Financial Statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Companyâs internal control.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by Management.
Conclude on the appropriateness of Managementâs use of the going concern basis of accounting in preparing the Financial Statements and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Companyâs ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditorâs report to the related disclosures in the Financial Statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditorâs report. However, future events or conditions may cause the Company to cease to continue as a going concern.
Evaluate the overall presentation, structure and contents of the Financial Statements, including the disclosures, and whether the Financial Statements represent the underlying transactions and events in a manner that gives a true and fair view.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
</g:StatementOfAuditorsResponsibilityForAuditAndAuditPerformed><h:ManagementsReview contextRef="c65">Financial Statements of Curasight ApS for 2016 has been prepared in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B as well as selected rules applying to reporting class C.
Main activity
The Companyâs business activity is to develop a diagnostic technology within nuclear medicine. In the financial year the Company has a new ownership group due to capital increase and strengthening the strategic platform.
Development in the year
The income statement of the Company for 2016 shows a loss of DKK 3,160,792, and at 31 December 2016 the balance sheet of the Company shows equity of DKK 7,707,781, which is in accordance to the budget. The management consider the results satisfactory.
Research and development activities
The Company does research and development with the purpose of development of novel and innovative diagnostic technologies within nuclear medicine. The Company has already successfully completed a phase I clinical trial at The Danish National University Hospital (Rigshospitalet), in cancer patients with very promising results. Furthermore, six additional phase II clinical trials in other cancer indications have been initiated and sponsored by Academia (Rigshospitalet and University of Copenhagen) with Curasight as collaborator, based on the Companyâs new product uTRACE®.
Outlook
The Company will complete a phase II clinical trial in breast cancer in Q1 2017. Based on predicted positive outcome, continued product development activities and work towards a phase III registration trial will be initiated, together with development of a go-to-market strategy. The Company expects a negative result for 2017 and an increase in cash liquidity resources according to the current investment agreement.
Events subsequent to the financial year
The company has planned a capital increase of a total value of DKK 11,361,750 in May 2017 (milestone 2 payment) after the approval of the Annual Report.
Subsequent events
No events materially affecting the assessment of the Annual Report have occurred after the balance sheet date.</h:ManagementsReview><e:fInformationOnSpecificPrerequisitesRegardingDevelopmentProjects contextRef="c65">
The project relates to the development of a new product uTRACE® which is a diagnostic platform for various cancer indications. The project is progressing as planned and is expected to be accomplished in 2019. uTRACE® is expected be sold to hospitals worldwide for diagnostic purposes of patients with different cancer indications. The company has so far conducted clinical investigations of more than 70 cancer patients, which has shown very positive results and led to the start-up of additional clinical studies in other cancer indications in collaboration with the University Hospital in Copenhagen (Rigshospitalet).</e:fInformationOnSpecificPrerequisitesRegardingDevelopmentProjects><e:DisclosureOfProvisionsForDeferredTax contextRef="c65">Intangible assets
2.899.296
701.958
Property, plant and equipment
17.483
0
Tax loss carry-forward
-1.506.258
-514.028
1.410.521
187.930</e:DisclosureOfProvisionsForDeferredTax><e:DisclosureOfContingentLiabilities contextRef="c65">Contingent liabilities
Curasight ApS has assumed renting obligations, which at the balance sheet date amounted to DKK 64.701 in the period of non-terminability.</e:DisclosureOfContingentLiabilities><e:InformationOnReportingClassOfEntity contextRef="c65">The Annual Report of Curasight ApS for 2016 has been prepared in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B as well as selected rules applying to reporting class C.
Financial Statements for 2016 are presented in DKK.</e:InformationOnReportingClassOfEntity><e:InformationOnChangesAndEffectsOfChangesOnRecognitionAndMeasurementBasisResultingFromChangesInAccountingEstimatesOrErrors contextRef="c65">Curasight ApS has implemented changes to the Danish Financial Statements Act, which comes into force per 1 January 2016, see law no. 738 of 1 June 2015.
Due to change in the Danish Financial Statement Act, an amount equal to the capitalized development costs in the balance held by 1 January 2016 are recognized in the item "reserve for development costs" under equity.
Other changes to the Danish Financial Statements Act, which comes into force on 1 January 2016 has not affected Curasight ApS' assets, liabilities and financial position. December 31, 2016, but only resulted in additional information in the annual report.</e:InformationOnChangesAndEffectsOfChangesOnRecognitionAndMeasurementBasisResultingFromChangesInAccountingEstimatesOrErrors><e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies contextRef="c65">Revenues are recognised in the income statement as earned. Furthermore, value adjustments of financial assets and liabilities measured at fair value or amortised cost are recognised. Moreover, all expenses incurred to achieve the earnings for the year are recognised in the income statement, including depreciation, amortisation, impairment losses and provisions as well as reversals due to changed accounting estimates of amounts that have previously been recognised in the income statement.
Assets are recognised in the balance sheet when it is probable that future economic benefits attributable to the asset will flow to the Company, and the value of the asset can be measured reliably.
Liabilities are recognised in the balance sheet when it is probable that future economic benefits will flow out of the Company, and the value of the liability can be measured reliably.
Assets and liabilities are initially measured at cost. Subsequently, assets and liabilities are measured as described for each item below.</e:DescriptionOfGeneralMattersRelatedToRecognitionMeasurementAndChangesInAccountingPolicies><e:DescriptionOfMethodsOfForeignCurrencies contextRef="c65">Transactions in foreign currencies are translated at the exchange rates at the dates of transaction. Exchange differences arising due to differences between the transaction date rates and the rates at the dates of payment are recognised in financial income and expenses in the income statement. Where foreign exchange transactions are considered hedging of future cash flows, the value adjustments are recognised directly in equity.
Receivables, payables and other monetary items in foreign currencies that have not been settled at the balance sheet date are translated at the exchange rates at the balance sheet date. Any differences between the exchange rates at the balance sheet date and the rates at the time when the receivable or the debt arose are recognised in financial income and expenses in the income statement.
Fixed assets acquired in foreign currencies are measured at the transaction date rates.</e:DescriptionOfMethodsOfForeignCurrencies><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfGrossProfitLoss contextRef="c65">With reference to section 32 of the Danish Financial Statements Act, revenue has not been disclosed in the Annual Report.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfGrossProfitLoss><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales contextRef="c65">Expenses for raw materials and consumables comprise the raw materials and consumables consumed to achieve revenue for the enterprice.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfCostOfSales><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses contextRef="c65">Other external expenses comprise indirect production costs and expenses for premises, sales and distribution as well as office expenses, etc.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense contextRef="c65">Staff expenses comprise wages and salaries as well as payroll expenses other than production wages.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense><e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation contextRef="c65">Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets and property, plant and equipment.</e:DescriptionOfMethodsOfImpairmentLossesAndDepreciation><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses contextRef="c65">Financial income and expenses are recognised in the income statement at the amounts relating to the financial year.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses contextRef="c65">Tax for the year consists of current tax for the year and changes in deferred tax for the year. The tax attributable to the profit for the year is recognised in the income statement, whereas the tax attributable to equity transactions is recognised directly in equity.
The Company is jointly taxed with wholly owned Danish and foreign subsidiaries. The tax effect of the joint taxation is allocated to enterprises in proportion to their taxable incomes.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxExpenses><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIntangibleAssets contextRef="c65">Intangible assets comprise uncompleted and completed development projects with related intellectual property rights, acquired intellectual property rights and includes salaries, amortization and other costs directly and indirectly attributable to the Company's development projects.
Development projects that are clearly defined and identifiable, where the technical utilization, sufficient resources and a potential future market or development opportunities in the Company can be demonstrated and where the intention is to produce, market or use the project are recognized as intangible assets if there is sufficient certainty that the capital value of future earnings can cover production costs, selling and administrative expenses and development costs.
Development projects that do not meet the criteria for capitalization are recognized as expenses in the income statement as incurred.
Capitalised development costs are measured at cost less accumulated depreciation and writedowns or recoverable amount, whichever is lower. An amount equal to the capitalized development costs in the balance held by 1 January 2016 are recognized in the item "reserve for development costs" under equity. The reserve decreased in value due to depreciation.
Completed development projects are amortised on a straight-line basis using the estimated useful lives of the assets. The amortisation period is 3 years.
Patents and licences are measured at the lower of cost less accumulated amortisation and recoverable amount. Patents are amortised over the remaining patent period, and licences are amortised over the licence period; however not exceeding 10 years.
Development costs and costs relating to rights developed by the Company are recognised in the income statement as costs in the year of acquisition.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfIntangibleAssets><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment contextRef="c65">Property, plant and equipment are measured at cost less accumulated depreciation and less any accumulated impairment losses.
Cost comprises the cost of acquisition and expenses directly related to the acquisition up until the time when the asset is ready for use.
Depreciation based on cost reduced by any residual value is calculated on a straight-line basis over the expected useful lives of the assets, which are:
Other fixtures and fittings, tools and equipment 10 years
Depreciation period and residual value are reassessed annually.
Assets costing less than DKK 12,900 are expensed in the year of acquisition.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfPropertyPlantAndEquipment><e:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets contextRef="c65">The carrying amounts of intangible assets and property, plant and equipment are reviewed on an annual basis to determine whether there is any indication of impairment other than that expressed by amortisation and depreciation.
If so, the asset is written down to its lower recoverable amount.</e:DescriptionOfMethodsOfAmortisationOfNoncurrentAssets><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables contextRef="c65">Receivables are measured in the balance sheet at the lower of amortised cost and net realisable value, which corresponds to nominal value less provisions for bad debts.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax contextRef="c65">Deferred income tax is measured using the balance sheet liability method in respect of temporary differences arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes on the basis of the intended use of the asset and settlement of the liability, respectively.
Deferred tax assets are measured at the value at which the asset is expected to be realised, either by elimination in tax on future earnings or by set-off against deferred tax liabilities within the same legal tax entity.
Deferred tax is measured on the basis of the tax rules and tax rates that will be effective under the legislation at the balance sheet date when the deferred tax is expected to crystallise as current tax. Any changes in deferred tax due to changes to tax rates are recognised in the income statement or in equity if the deferred tax relates to items recognised in equity.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfTaxPayablesAndDeferredTax><e:DescriptionOfMethodsOfCurrentTaxReceivablesAndLiabilities contextRef="c65">Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses.</e:DescriptionOfMethodsOfCurrentTaxReceivablesAndLiabilities><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions contextRef="c65">Debts are measured at amortised cost, substantially corresponding to nominal value.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions><e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeLiabilities contextRef="c65">Deferred income comprises payments received in respect of income in subsequent years.</e:DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfDeferredIncomeLiabilities><!--Virksomhedskapital aktuel primo--><context id="c0"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-01-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital aktuel i aaret--><context id="c1"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Virksomhedskapital aktuel ultimo--><context id="c2"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Overkurs emission aktuel primo--><context id="c5"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-01-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:SharePremiumMember</xbrldi:explicitMember></scenario></context><!--Overkurs emission aktuel i aaret--><context id="c6"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:SharePremiumMember</xbrldi:explicitMember></scenario></context><!--Overkurs emission aktuel ultimo--><context id="c7"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:SharePremiumMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel primo--><context id="c20"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-01-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel i aaret--><context id="c21"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfort res aktuel ultimo--><context id="c22"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Aktuelle periode enkelt selskab--><context id="c65"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period></context><!--REVISOR2--><context id="c66"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfAuditorDimension"><d:auditorIdentifier>2</d:auditorIdentifier></xbrldi:typedMember></scenario></context><!--REVISOR1--><context id="c67"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfAuditorDimension"><d:auditorIdentifier>1</d:auditorIdentifier></xbrldi:typedMember></scenario></context><!--BOARD1--><context id="c68"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>1</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD2--><context id="c69"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>2</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD3--><context id="c70"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>3</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD4--><context id="c71"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>4</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD5--><context id="c72"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>5</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--BOARD6--><context id="c73"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfSupervisoryBoardDimension"><d:memberOfBoardIdentifier>6</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--CEO1--><context id="c83"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:typedMember dimension="d:IdentificationOfMemberOfExecutiveBoardDimension"><d:memberOfBoardIdentifier>1</d:memberOfBoardIdentifier></xbrldi:typedMember></scenario></context><!--Forrige periode enkelt selskab--><context id="c92"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2015-01-01</startDate><endDate>2015-12-31</endDate></period></context><!--Overfoert resultat aktuel i aaret--><context id="c105"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ResultDistributionDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Overfoert resultat forrige i aaret--><context id="c106"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2015-01-01</startDate><endDate>2015-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ResultDistributionDimension">e:RetainedEarningsMember</xbrldi:explicitMember></scenario></context><!--Slutdato forrige periode enkelt selskab--><context id="c109"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2015-12-31</instant></period></context><!--Slutdato aktuelle periode enkelt selskab--><context id="c110"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period></context><!--Aktiespec Besk1--><context id="c119"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:typedMember dimension="e:IdentificationOfClassOfSharesDimension"><e:classOfSharesIdentifier>1</e:classOfSharesIdentifier></xbrldi:typedMember></scenario></context><!--Aktiespec Besk2--><context id="c120"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:typedMember dimension="e:IdentificationOfClassOfSharesDimension"><e:classOfSharesIdentifier>2</e:classOfSharesIdentifier></xbrldi:typedMember></scenario></context><!--Aktiespec Besk3--><context id="c121"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:typedMember dimension="e:IdentificationOfClassOfSharesDimension"><e:classOfSharesIdentifier>3</e:classOfSharesIdentifier></xbrldi:typedMember></scenario></context><!--Kapital aktuel primo forrige aar--><context id="c123"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-01-01</instant></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:PreviousYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Kapital aktuel i aaret forrige aar--><context id="c124"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:PreviousYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Kapital aktuel ultimo forrige aar--><context id="c125"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:PreviousYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Kapital aktuel primo forrige aar 2--><context id="c126"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-01-01</instant></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:TwoYearsAgoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Kapital aktuel i aaret forrige aar 2--><context id="c127"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:TwoYearsAgoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Kapital aktuel ultimo forrige aar 2--><context id="c128"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:TwoYearsAgoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Kapital aktuel primo forrige aar 3--><context id="c129"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-01-01</instant></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:ThreeYearsAgoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Kapital aktuel i aaret forrige aar 3--><context id="c130"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:ThreeYearsAgoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Kapital aktuel ultimo forrige aar 3--><context id="c131"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:explicitMember dimension="d:RetrospectiveInformationDimension">d:ThreeYearsAgoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ContributedCapitalMember</xbrldi:explicitMember></scenario></context><!--Andre anlag aktuel primo--><context id="c188"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-01-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember></scenario></context><!--Andre anlag aktuel i aaret--><context id="c189"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember></scenario></context><!--Andre anlag aktuel ultimo--><context id="c190"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfPropertyPlantAndEquipmentDimension">e:FixturesFittingsToolsAndEquipmentMember</xbrldi:explicitMember></scenario></context><!--UdvProject aktuel primo--><context id="c329"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-01-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:CompletedDevelopmentProjectsMember</xbrldi:explicitMember></scenario></context><!--Erhvervede_patenter aktuel primo--><context id="c330"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-01-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:AcquiredPatentsMember</xbrldi:explicitMember></scenario></context><!--UdvProjekt_U_Udforelse aktuel primo--><context id="c332"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-01-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:DevelopmentProjectsInProgressMember</xbrldi:explicitMember></scenario></context><!--UdvProjekt_U_Udforelse aktuel i aaret--><context id="c336"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:DevelopmentProjectsInProgressMember</xbrldi:explicitMember></scenario></context><!--UdvProjekt_U_Udforelse aktuel ultimo--><context id="c337"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:DevelopmentProjectsInProgressMember</xbrldi:explicitMember></scenario></context><!--Erhvervede_patenter aktuel i aaret--><context id="c340"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:AcquiredIntangibleAssetsMember</xbrldi:explicitMember></scenario></context><!--Erhvervede_patenter aktuel ultimo--><context id="c341"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:AcquiredIntangibleAssetsMember</xbrldi:explicitMember></scenario></context><!--UdvProject aktuel i aaret--><context id="c342"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:CompletedDevelopmentProjectsMember</xbrldi:explicitMember></scenario></context><!--UdvProject aktuel ultimo--><context id="c343"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfIntangibleAssetsDimension">e:CompletedDevelopmentProjectsMember</xbrldi:explicitMember></scenario></context><!--Reserve for udviklingsomkostninger aktuel primo--><context id="c2473"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-01-01</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForDevelopmentExpenditureMember</xbrldi:explicitMember></scenario></context><!--Reserve for udviklingsomkostninger aktuel i aaret--><context id="c2474"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><startDate>2016-01-01</startDate><endDate>2016-12-31</endDate></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForDevelopmentExpenditureMember</xbrldi:explicitMember></scenario></context><!--Reserve for udviklingsomkostninger aktuel ultimo--><context id="c2475"><entity><identifier scheme="http://www.dcca.dk/cvr">35249389</identifier></entity><period><instant>2016-12-31</instant></period><scenario><xbrldi:explicitMember dimension="e:ClassesOfEquityDimension">e:ReserveForDevelopmentExpenditureMember</xbrldi:explicitMember></scenario></context><!--DKK enere--><unit id="u0"><measure>iso4217:DKK</measure></unit><!--Antal--><unit id="u2"><measure>xbrli:pure</measure></unit><!--Aktier--><unit id="u3"><measure>xbrli:shares</measure></unit></xbrl>